SolarMax Technology enters the back half of May having just delivered its best quarterly revenue print in at least a year — and the stock is still down 9% on the week.
That gap between fundamentals and price is the central tension here. Q1 revenue came in at $14.8 million, more than double the $6.9 million reported in the same quarter a year ago. The loss per share narrowed to just one cent from three cents a year ago. The 10-Q dropped on May 15, and next Thursday (May 21) brings what the calendar lists as the next scheduled event. Yet the stock closed at $0.54, its lowest level in months, and is down more than 10% over the past 30 days.
The lending market tells a relatively relaxed story for a micro-cap under pressure. Short interest has actually been unwinding — down roughly 17% week-on-week to around 580,000 shares, and off more than 15% from a month ago. That compares with a peak near 920,000 shares in early April. At 1.4% of the free float, this is not a heavily shorted name, and the direction is clearly towards covering rather than building. Borrow availability is running at roughly 207% of current short interest — meaning there are more than twice as many shares available to lend as are currently borrowed — which puts this firmly in the normal-to-loose range. Cost to borrow has held steady, oscillating in a narrow band between 6.2% and 6.9% for most of the past six weeks, with no sign of a squeeze dynamic. The ORTEX short score of 51.1, which has drifted down from a month-high near 54, reinforces the read: shorts are modest and retreating, not building a conviction trade.
The ownership picture is dominated by insiders and strategic holders. The two largest holders by name — David Hsu (7.1%) and Changzhou Almaden (6.3%) — have reported no changes to their stakes since October 2025. Institutional ownership is thin. Vanguard added roughly 63,000 shares as of end-March, and BlackRock added around 19,000 shares through end-April, but both positions are well under 1.5% of shares. These are passive index flows, not active conviction bets. Two Sigma trimmed meaningfully — shedding around 162,000 shares as of year-end 2025 — which represents the most notable institutional exit in the recent filing history.
The earnings reaction data from prior quarters frames the risk clearly. The April 7 announcement produced a 23% one-day drop and a further 14% five-day loss. The April 6 filing before it generated a 13% fall on the day and a 16% slide over the week that followed. Even the November 2025 print, which was the mildest of the three, closed the week lower. Three consecutive releases, three consecutive negative reactions — the pattern is consistent, though the scale varies significantly.
With Q1 results now filed and another event on the calendar for May 21, the question is whether the revenue doubling is enough to interrupt that streak — or whether the stock's continued drift lower after the print suggests the market has already made its assessment.
See the live data behind this article on ORTEX.
Open SMXT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
